Current Experience and Future Directions in Therapy
- 8 Downloads
KeywordsThymoma Thymic Carcinoma Cancer Treatment Report Thymic Epithelial Tumor Invasive Thymoma
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Unable to display preview. Download preview PDF.
- Bonomi P, Aisner S, Ettinger D, Finkelstein D. Phase II trial of cisplatin in recurrent or metastatic malignant thymoma: an ECOG trial. Proceedings of the American Society of Clinical Oncology 7: 221, 1988Google Scholar
- Donovan PJ, Foley JF. Chemotherapy in invasive thymomas: five case reports. Journal of Surgical Oncology (New York) 33: 14–17, 1986Google Scholar
- Harper PG, Highley M, Rankin E, Dussek J, Bryant B, et al. Ifosfamide monotherapy demonstrates high activity in malignant thymoma. Proceedings of the American Society of Clinical Oncology 10: 1049, 1991Google Scholar
- Harper P, Addis B. Unusual tumors of the medastinum. In Williams et al. (Eds) Textbook of uncommon cancer, pp. 411–448, John Wiley & Sons, Chichester, 1988Google Scholar
- Michon JM, Caligiuri MA, Hazanow SM, Levine H, Schloss-man SF, et al. Induction of natural killer effectors form human thymus with recombinant interleukin-2. Journal of Immunology 140: 3660–3667, 1988Google Scholar
- Phillips J, Lanier L. Acquisition of non-MHC restricted cytotoxic function by IL-2 activated thymocytes with an ‘immature’ antigenic phenotype. Journal of Immunology 139: 638–687, 1987Google Scholar
- Ribeiro RC, Patton DF, Jenkins J, Sixby JW. Thymic carcinoma with a defective Epstein-Barr virus encoding the BZLF1 trans-activator. Proceedings of the American Society of Clinical Oncology 10: 76, 1991Google Scholar
- Rosenberg JC. Neoplasms of the mediastinum. In DeVita et al. (Eds) Cancer principles and practice of oncology, Vol. 1, pp. 706–724, JB Lippincott, Philadelphia, 1989Google Scholar
- Stolinsky DC, Hum GJ, Jacobs EM, Solomon J, Bateman JR. Clinical trial of weekly doses of vinblastine (NSC-49842) combined with vincristine (NSC-67574) in malignant lymphoma and other neoplasms. Cancer Chemotherapy Reports 57: 477–484, 1973Google Scholar
© Adis International Limited 1993